Variant report
Variant | nsv613074 |
---|---|
Chromosome Location | chr9:1503556-1513849 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1576747 | chr9:1503556-1503557 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs543980563 | chr9:1503602-1503603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1576746 | chr9:1503647-1503648 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs147776257 | chr9:1503648-1503649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546825395 | chr9:1503663-1503664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs116789022 | chr9:1503678-1503679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs367924673 | chr9:1503693-1503694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529591807 | chr9:1503699-1503700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548921548 | chr9:1503708-1503709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553697207 | chr9:1503713-1503714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371353928 | chr9:1503716-1503717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569171059 | chr9:1503742-1503743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538305300 | chr9:1503753-1503754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557990326 | chr9:1503782-1503783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374120145 | chr9:1503806-1503807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573514871 | chr9:1503827-1503828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553242688 | chr9:1503844-1503845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192097168 | chr9:1503859-1503860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10756630 | chr9:1503869-1503870 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs78029883 | chr9:1503876-1503877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575146438 | chr9:1503891-1503892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544224032 | chr9:1503892-1503893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564009793 | chr9:1503896-1503897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372030072 | chr9:1503901-1503902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs58945952 | chr9:1503910-1503911 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs183847258 | chr9:1503920-1503921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs139427573 | chr9:1503923-1503924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145137952 | chr9:1503956-1503957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549429397 | chr9:1503964-1503965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10961807 | chr9:1503981-1503982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569203725 | chr9:1503991-1503992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531583337 | chr9:1504008-1504009 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs551785035 | chr9:1504018-1504019 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571639614 | chr9:1504053-1504054 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534335515 | chr9:1504076-1504077 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546768675 | chr9:1504079-1504080 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566682525 | chr9:1504094-1504095 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs80351974 | chr9:1504097-1504098 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147585520 | chr9:1504101-1504102 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575530011 | chr9:1504131-1504132 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187624332 | chr9:1504162-1504163 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557782346 | chr9:1504170-1504171 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577273320 | chr9:1504184-1504185 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539950810 | chr9:1504191-1504192 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190699669 | chr9:1504195-1504196 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182374057 | chr9:1504205-1504206 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187044965 | chr9:1504206-1504207 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78165500 | chr9:1504216-1504217 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368714083 | chr9:1504223-1504224 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532070544 | chr9:1504234-1504235 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1491000-1504000 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr9:1504000-1504800 | Strong transcription | Adipose Nuclei | Adipose |
3 | chr9:1504800-1513800 | Weak transcription | Adipose Nuclei | Adipose |
4 | chr9:1511000-1511200 | Enhancers | NHEK | skin |
5 | chr9:1512600-1513000 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr9:1512800-1514200 | Enhancers | NHEK | skin |
7 | chr9:1513000-1513400 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr9:1513000-1513800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr9:1513200-1514000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr9:1513400-1514800 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr9:1513800-1514600 | Enhancers | Adipose Nuclei | Adipose |